Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$73.98 USD
+0.51 (0.69%)
Updated May 1, 2024 04:00 PM ET
After-Market: $74.00 +0.02 (0.03%) 4:34 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: BMO |
3/2024 | $0.86 | 0.00% |
Earnings Summary
For their last quarter, Dr. Reddys Laboratories (RDY) reported earnings of $0.99 per share, beating the Zacks Consensus Estimate of $0.87 per share. This reflects a positive earnings surprise of 13.79%. Look out for RDY's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of $0.86 per share, reflecting a year-over-year increase of 22.86%.
Earnings History
Price & Consensus
Zacks News for RDY
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
RDY: What are Zacks experts saying now?
Zacks Private Portfolio Services